{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:25:38Z","timestamp":1789579538751,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.intimp.2022.108703","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T15:40:42Z","timestamp":1647531642000},"page":"108703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Acetyl-11-keto-\u03b2-boswellic acid improves clinical symptoms through modulation of Nrf2 and NF-\u03baB pathways in SJL\/J mouse model of experimental autoimmune encephalomyelitis"],"prefix":"10.1016","volume":"107","author":[{"given":"Ahmed","family":"Nadeem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh F.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naif O.","family":"Al-Harbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wedad","family":"Sarawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabry M","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael A.","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid E","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sary","family":"Alsanea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh A.","family":"Alqarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali S.","family":"Alfardan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh A.","family":"Bakheet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2022.108703_b0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s12017-019-08569-z","article-title":"Acetyl-11-keto-\u03b2-boswellic acid (AKBA) attenuates oxidative stress, inflammation, complement activation and cell death in brain endothelial cells following OGD\/reperfusion","volume":"21","author":"Ahmad","year":"2019","journal-title":"Neuromol. Med."},{"issue":"7","key":"10.1016\/j.intimp.2022.108703_b0010","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3390\/pharmaceutics13070925","article-title":"Pharmacological inhibition of STAT3 by stattic ameliorates clinical symptoms and reduces autoinflammation in myeloid, lymphoid, and neuronal tissue compartments in relapsing-remitting model of experimental autoimmune encephalomyelitis in SJL\/J mice","volume":"13","author":"Alhazzani","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2022.108703_b0015","doi-asserted-by":"crossref","first-page":"153002","DOI":"10.1016\/j.phymed.2019.153002","article-title":"Boswellic extracts and 11-keto-\u00df-boswellic acids prevent type 1 and type 2 diabetes mellitus by suppressing the expression of proinflammatory cytokines","volume":"63","author":"Ammon","year":"2019","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.intimp.2022.108703_b0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay","volume":"239","author":"Benzie","year":"1996","journal-title":"Anal Biochem."},{"issue":"4","key":"10.1016\/j.intimp.2022.108703_b0025","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jnr.10408","article-title":"Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels","volume":"70","author":"Calabrese","year":"2002","journal-title":"J. Neurosci. Res."},{"issue":"2","key":"10.1016\/j.intimp.2022.108703_b0030","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/ATVBAHA.107.155606","article-title":"Antiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE-\/- mice","volume":"28","author":"Cuaz-P\u00e9rolin","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.intimp.2022.108703_b0035","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.108703_b0040","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.1038\/srep07002","article-title":"Neuroprotection by acetyl-11-keto-\u03b2-Boswellic acid, in ischemic brain injury involves the Nrf2\/HO-1 defense pathway","volume":"11","author":"Ding","year":"2014","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2022.108703_b0045","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/brain\/aws012","article-title":"NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury","volume":"135","author":"Fischer","year":"2012","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.intimp.2022.108703_b0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrneurol.2014.37","article-title":"Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis","volume":"10","author":"Friese","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.intimp.2022.108703_b0055","doi-asserted-by":"crossref","first-page":"a028977","DOI":"10.1101\/cshperspect.a028977","article-title":"Experimental autoimmune encephalomyelitis (EAE) as animal models of multiple sclerosis (MS)","volume":"8","author":"Glatigny","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"2","key":"10.1016\/j.intimp.2022.108703_b0060","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neulet.2008.08.035","article-title":"Elevated myeloperoxidase activity in white matter in multiple sclerosis","volume":"444","author":"Gray","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.intimp.2022.108703_b0065","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.3389\/fimmu.2017.01922","article-title":"Role of nuclear factor (erythroid-derived 2)-like 2 signaling for effects of fumaric acid esters on dendritic cells","volume":"22","author":"Hammer","year":"2017","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2022.108703_b0070","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cyto.2015.01.009","article-title":"Seeking balance: potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10","volume":"73","author":"Ireland","year":"2015","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.intimp.2022.108703_b0075","doi-asserted-by":"crossref","first-page":"115327","DOI":"10.1016\/j.bmc.2020.115327","article-title":"A panoramic review of IL-6: structure, pathophysiological roles and inhibitors","volume":"28","author":"Kaur","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.intimp.2022.108703_b0080","doi-asserted-by":"crossref","first-page":"105211","DOI":"10.1016\/j.neuint.2021.105211","article-title":"Withametelin, a novel phytosterol, alleviates neurological symptoms in EAE mouse model of multiple sclerosis via modulation of Nrf2\/HO-1 and TLR4\/NF-\u03baB signaling","volume":"151","author":"Khan","year":"2021","journal-title":"Neurochem. Int."},{"issue":"10","key":"10.1016\/j.intimp.2022.108703_b0085","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.neuron.2021.03.005","article-title":"SnapShot: neuronal dysfunction in inflammation","volume":"109","author":"Kneussel","year":"2021","journal-title":"Neuron"},{"issue":"22","key":"10.1016\/j.intimp.2022.108703_b0090","first-page":"1503","article-title":"Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis","volume":"30","author":"Larabee","year":"2016","journal-title":"Mol. Vis."},{"issue":"11","key":"10.1016\/j.intimp.2022.108703_b0095","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis","volume":"8","author":"Lassmann","year":"2012","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.intimp.2022.108703_b0100","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0002-9440(10)64677-9","article-title":"Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions","volume":"158","author":"Liu","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2022.108703_b0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.intimp.2022.108703_b0110","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1124\/jpet.108.137208","article-title":"Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice","volume":"326","author":"Masood","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2022.108703_b0115","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41590-020-0654-0","article-title":"Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation","volume":"21","author":"Mendiola","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2022.108703_b0120","doi-asserted-by":"crossref","first-page":"172973","DOI":"10.1016\/j.ejphar.2020.172973","article-title":"Targeting Keap1\/Nrf2\/ARE signaling pathway in multiple sclerosis","volume":"873","author":"Michali\u010dkov\u00e1","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2022.108703_b0125","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/jnc.13837","article-title":"Nrf2-dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitis","volume":"139","author":"Morales Pantoja","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2022.108703_b0130","doi-asserted-by":"crossref","first-page":"107323","DOI":"10.1016\/j.intimp.2020.107323","article-title":"Aggravation of autism-like behavior in BTBR T+tf\/J mice by environmental pollutant, di-(2-ethylhexyl) phthalate: Role of nuclear factor erythroid 2-related factor 2 and oxidative enzymes in innate immune cells and cerebellum","volume":"91","author":"Nadeem","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108703_b0135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pupt.2014.06.001","article-title":"Airway and systemic oxidant-antioxidant dysregulation in asthma: a possible scenario of oxidants spill over from lung into blood","volume":"29","author":"Nadeem","year":"2014","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2022.108703_b0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2017.05.018","article-title":"IL-17A causes depression-like symptoms via NF\u03baB and p38MAPK signaling pathways in mice: implications for psoriasis associated depression","volume":"97","author":"Nadeem","year":"2017","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.intimp.2022.108703_b0145","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nm.2324","article-title":"A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"17","author":"Niki\u0107","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2022.108703_b0150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.expneurol.2015.11.010","article-title":"Oxidative stress in multiple sclerosis: Central and peripheral mode of action","volume":"277","author":"Ohl","year":"2016","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108703_b0155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1155\/2009\/325847","article-title":"Oxidative stress is increased in serum from Mexican patients with relapsing-remitting multiple sclerosis","volume":"26","author":"Ortiz","year":"2009","journal-title":"Dis. Markers"},{"key":"10.1016\/j.intimp.2022.108703_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/708659","article-title":"Immunology and oxidative stress in multiple sclerosis: clinical and basic approach","volume":"2013","author":"Ortiz","year":"2013","journal-title":"Clin. Dev. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2022.108703_b0165","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.arcmed.2014.11.013","article-title":"Role of the blood-brain barrier in multiple sclerosis","volume":"45","author":"Ortiz","year":"2014","journal-title":"Arch. Med. Res."},{"issue":"11","key":"10.1016\/j.intimp.2022.108703_b0170","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/glia.23033","article-title":"TGF\u03b2 regulates persistent neuroinflammation by controlling Th1 polarization and ROS production via monocyte-derived dendritic cells","volume":"64","author":"Parsa","year":"2016","journal-title":"Glia"},{"issue":"759","key":"10.1016\/j.intimp.2022.108703_b0175","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2015.03.042","article-title":"Animal models of multiple sclerosis","volume":"15","author":"Procaccini","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2022.108703_b0180","first-page":"215","article-title":"Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis","volume":"14","author":"Romme Christensen","year":"2012","journal-title":"J. Neuroinflamm."},{"issue":"3-4","key":"10.1016\/j.intimp.2022.108703_b0185","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1089\/ars.2006.8.653","article-title":"Regulation of vascular responses to inflammation: inducible matrix metalloproteinase-3 expression in human microvascular endothelial cells is sensitive to antiinflammatory Boswellia","volume":"8","author":"Roy","year":"2006","journal-title":"Antioxid. Redox. Signal."},{"issue":"2","key":"10.1016\/j.intimp.2022.108703_b0190","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI200316721","article-title":"Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses","volume":"111","author":"Sanna","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.intimp.2022.108703_b0195","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/jnen\/65.2.124","article-title":"Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells","volume":"65","author":"Serafini","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.intimp.2022.108703_b0200","doi-asserted-by":"crossref","first-page":"100019","DOI":"10.1016\/j.dscb.2021.100019","article-title":"Targeting Nrf2\/HO-1 anti-oxidant signaling pathway in the progression of multiple sclerosis and influences on neurological dysfunctions","volume":"3","author":"Upadhayay","year":"2021","journal-title":"Brain Disorders"},{"issue":"1","key":"10.1016\/j.intimp.2022.108703_b0205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1750-3639.1999.tb00212.x","article-title":"Demyelination: the role of reactive oxygen and nitrogen species","volume":"9","author":"Smith","year":"1999","journal-title":"Brain Pathol."},{"issue":"3","key":"10.1016\/j.intimp.2022.108703_b0210","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s12031-020-01672-y","article-title":"Oxidative\/nitroxidative stress and multiple sclerosis","volume":"71","author":"Tobore","year":"2021","journal-title":"J. Mol. Neurosci."},{"issue":"8","key":"10.1016\/j.intimp.2022.108703_b0215","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.freeradbiomed.2010.07.013","article-title":"Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions","volume":"49","author":"van Horssen","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2022.108703_b0220","doi-asserted-by":"crossref","first-page":"106187","DOI":"10.1016\/j.intimp.2020.106187","article-title":"Molecular control of pathogenic Th17 cells in autoimmune diseases","volume":"80","author":"Wu","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"24","key":"10.1016\/j.intimp.2022.108703_b0225","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.7150\/thno.35988","article-title":"Acetyl-11-keto-\u03b2-boswellic acid attenuates titanium particle-induced osteogenic inhibition via activation of the GSK-3\u03b2\/\u03b2-catenin signaling pathway","volume":"9","author":"Xiong","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.intimp.2022.108703_b0230","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000452744","article-title":"Nrf2- and bach1 may play a role in the modulation of ultraviolet a-induced oxidative stress by acetyl-11-keto-\u03b2-boswellic acid in skin keratinocytes","volume":"30","author":"Yang","year":"2017","journal-title":"Skin Pharmacol. Physiol."},{"issue":"11","key":"10.1016\/j.intimp.2022.108703_b0235","doi-asserted-by":"crossref","first-page":"593368","DOI":"10.3389\/fimmu.2020.593368","article-title":"Bixin attenuates experimental autoimmune encephalomyelitis by suppressing TXNIP\/NLRP3 inflammasome activity and activating NRF2 signaling","volume":"9","author":"Yu","year":"2020","journal-title":"Front. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922001874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922001874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:38:01Z","timestamp":1761586681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922001874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":47,"alternative-id":["S1567576922001874"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108703","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetyl-11-keto-\u03b2-boswellic acid improves clinical symptoms through modulation of Nrf2 and NF-\u03baB pathways in SJL\/J mouse model of experimental autoimmune encephalomyelitis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108703"}}